drugset
drugset / Trial / NCT00357630

Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary

NCT00357630 ↗

Phase 2 Completed 52 enrolled Eastern Cooperative Oncology Group National Cancer Institute (NCI) · collab
Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well gemcitabine works in treating patients with metastatic cancer of unknown primary.

Timeline

Start
2006-06
Primary completion
2007-02
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule — Intravenous

Indications

cancer of unknown primary site